Infectious Diseases Trial of a Long-Acting Malaria Drug Injection Launches in RwandaGlobal Biodefense StaffNovember 5, 2026
CBRNE Radiation Countermeasure Entolimod Clears Mouse Safety Study, Moves to Survival TestGlobal Biodefense StaffNovember 3, 2026
Medical Countermeasures UK Commits £33.2 Million to Eight Vaccine Projects Targeting Ebola, Marburg, Plague and Other Epidemic ThreatsGlobal Biodefense StaffOctober 18, 2026
New Vaccine Protects Against Lethal Pneumonia Caused by Staph Antimicrobial Resistance December 31, 2013 …
Outbreak at Princeton Calls for “Compassionate Use” of Unlicensed Vaccine Medical Countermeasures December 27, 2013 …
NIH Projects Advance Treatment for Acute Radiation Syndrome, TBI Medical Countermeasures December 17, 2013 …
RFP: Phase I Clinical Trial Unit for Infectious Disease Therapeutics Contracts + Grants December 17, 2013 …
Laser Light Treatment May Boost Flu Vaccine Effectiveness Medical Countermeasures December 12, 2013 …
New Inhibitors Could Help with Treatments for Anthrax, MRSA Antimicrobial Resistance November 26, 2013 …
Theraclone Announces Positive Results for Universal Flu Drug Medical Countermeasures November 18, 2013 …
Influenza Drug Under DoD Development Completes Second Clinical Trial Defense + Military November 13, 2013 …